Our Fisher Clinical ServicesSM offerings are now part of the Patheon brand portfolio by Thermo Fisher Scientific. Please update your bookmark.
Post Pandemic Planning: What Will Change in Early-Phase Drug Development?
Watch as our early development experts discuss the impact of COVID-19 on sponsor/CDMO relationships moving forward, how Thermo Fisher Scientific has maintained normal CDMO operations and plans to shift to meet new needs and more.